APA (7th ed.) Citation

Escobar, C., Barrios, V., Lip, G. Y. H., Amin, A. N., Auladell-Rispau, A., Santero, M., . . . Requeijo, C. (2022). Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis. Clinical Drug Investigation, 42(3), 279. https://doi.org/10.1007/s40261-022-01126-w

Chicago Style (17th ed.) Citation

Escobar, Carlos, Vivencio Barrios, Gregory Y. H. Lip, Alpesh N. Amin, Ariadna Auladell-Rispau, Marilina Santero, Josefina Salazar, and Carolina Requeijo. "Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis." Clinical Drug Investigation 42, no. 3 (2022): 279. https://doi.org/10.1007/s40261-022-01126-w.

MLA (9th ed.) Citation

Escobar, Carlos, et al. "Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis." Clinical Drug Investigation, vol. 42, no. 3, 2022, p. 279, https://doi.org/10.1007/s40261-022-01126-w.